X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Tata Investment Corporation with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TATA INVEST. CORP. vs INDOCO REMEDIES - Comparison Results

TATA INVEST. CORP.    Change

Tata Investment Corporation is more than 70 years old. It is a non banking financial company (NBFC). The stated objective of the company is to invest in Tata and non-Tata companies, both in the listed and unlisted categories. However, investments in ... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TATA INVEST. CORP. INDOCO REMEDIES TATA INVEST. CORP./
INDOCO REMEDIES
 
P/E (TTM) x 24.9 85.2 29.2% View Chart
P/BV x 2.2 3.1 72.1% View Chart
Dividend Yield % 2.0 0.7 266.7%  

Financials

 TATA INVEST. CORP.   INDOCO REMEDIES
EQUITY SHARE DATA
    TATA INVEST. CORP.
Mar-14
INDOCO REMEDIES
Mar-17
TATA INVEST. CORP./
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs505360 140.1%   
Low Rs348249 139.5%   
Sales per share (Unadj.) Rs39.6119.0 33.2%  
Earnings per share (Unadj.) Rs33.88.4 404.3%  
Cash flow per share (Unadj.) Rs33.815.2 222.1%  
Dividends per share (Unadj.) Rs17.001.60 1,062.5%  
Dividend yield (eoy) %4.00.5 759.6%  
Book value per share (Unadj.) Rs390.370.7 552.0%  
Shares outstanding (eoy) m55.1092.15 59.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x10.82.6 420.9%   
Avg P/E ratio x12.636.4 34.6%  
P/CF ratio (eoy) x12.620.0 63.0%  
Price / Book Value ratio x1.14.3 25.3%  
Dividend payout %50.319.1 262.8%   
Avg Mkt Cap Rs m23,48928,083 83.6%   
No. of employees `000NA6.0 0.0%   
Total wages/salary Rs m782,167 3.6%   
Avg. sales/employee Rs ThNM1,817.0-  
Avg. wages/employee Rs ThNM359.0-  
Avg. net profit/employee Rs ThNM127.7-  
INCOME DATA
Net Sales Rs m2,18010,968 19.9%  
Other income Rs m2440 59.4%   
Total revenues Rs m2,20311,007 20.0%   
Gross profit Rs m2,0211,565 129.2%  
Depreciation Rs m1633 0.2%   
Interest Rs m062 0.0%   
Profit before tax Rs m2,044909 224.7%   
Minority Interest Rs m-10-   
Prior Period Items Rs m1120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m292139 210.5%   
Profit after tax Rs m1,863771 241.7%  
Gross profit margin %92.714.3 650.0%  
Effective tax rate %14.315.3 93.7%   
Net profit margin %85.57.0 1,216.3%  
BALANCE SHEET DATA
Current assets Rs m2,6765,725 46.8%   
Current liabilities Rs m1,1885,454 21.8%   
Net working cap to sales %68.32.5 2,766.8%  
Current ratio x2.31.0 214.7%  
Inventory Days Days062 0.0%  
Debtors Days Days372 4.1%  
Net fixed assets Rs m1365,307 2.6%   
Share capital Rs m551184 299.0%   
"Free" reserves Rs m16,3736,331 258.6%   
Net worth Rs m21,5066,516 330.1%   
Long term debt Rs m01,323 0.0%   
Total assets Rs m22,73611,970 189.9%  
Interest coverage xNM15.6-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.10.9 10.5%   
Return on assets %8.27.0 117.8%  
Return on equity %8.711.8 73.2%  
Return on capital %10.012.4 80.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m01,141 0.0%   
Net fx Rs m03,366 0.0%   
CASH FLOW
From Operations Rs m840886 94.7%  
From Investments Rs m-451-1,706 26.4%  
From Financial Activity Rs m-1,0321,316 -78.4%  
Net Cashflow Rs m-643497 -129.5%  

Share Holding

Indian Promoters % 73.0 59.2 123.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.5 12.5 36.0%  
FIIs % 1.5 6.0 25.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.0 22.4 93.8%  
Shareholders   25,758 12,805 201.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TATA INVEST. CORP. With:   S.P. APPARELS LTD  COX & KINGS  COMMEX TECHNOLOGY  THOMAS COOK INDIA  MIC ELECTRONICS  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 139.4% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, INDOCO REMEDIES has posted a net profit of Rs 78 m (down 139.4% YoY). Sales on the other hand came in at Rs 2 bn (down 17.3% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

TATA INVEST. CORP. Announces Quarterly Results (2QFY19); Net Profit Down 21.1% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TATA INVEST. CORP. has posted a net profit of Rs 913 m (down 21.1% YoY). Sales on the other hand came in at Rs 1 bn (down 30.3% YoY). Read on for a complete analysis of TATA INVEST. CORP.'s quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TATA INVEST. CORP. SHARE PRICE


Dec 12, 2018 (Close)

TRACK TATA INVEST. CORP.

  • Track your investment in TATA INVEST. CORP. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TATA INVEST. CORP.

TATA INVEST. CORP. 5-YR ANALYSIS

COMPARE TATA INVEST. CORP. WITH

MARKET STATS